{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT00883727",
      "OrgStudyIdInfo": {
        "OrgStudyId": "SRPL/AMI/07-08/001"
      },
      "Organization": {
        "OrgFullName": "Stempeutics Research Pvt Ltd",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI",
      "OfficialTitle": "A Randomized, Double Blind, Multicentric, Placebo Controlled, Single Dose, Phase - i/ii Study Assessing the Safety and Efficacy of Intravenous ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With st Elevated Acute Myocardial Infarction (Stemi)"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2013",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 2009"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "May 2010",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "August 2012",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "April 17, 2009",
      "StudyFirstSubmitQCDate": "April 17, 2009",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 20, 2009",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "March 4, 2013",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 5, 2013",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Stempeutics Research Pvt Ltd",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "This clinical trial aims to find out the safety and efficacy of adult mesenchymal stem cells in patients with myocardial infarction."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Myocardial Infarction"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "mesenchymal stem cells",
          "myocardial infarction"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Triple",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Care Provider",
              "Investigator"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "20",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Stem cell"
              ]
            }
          },
          {
            "ArmGroupLabel": "Placebo",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Plasmalyte A"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "Stem cell",
            "InterventionDescription": "IV infusion of stem cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "stem cells"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Plasmalyte A",
            "InterventionDescription": "IV infusion",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Placebo"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "AE and ECG parameters",
            "PrimaryOutcomeTimeFrame": "6 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Regional myocardial perfusion and infarct size",
            "SecondaryOutcomeTimeFrame": "6 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with STEMI aged between 20 and 70 years, either males or females with non-child bearing potential, after 2 days of successful PCI.\nPatient has global left ventricular systolic dysfunction with an ejection fraction of <50% and >30%.\nECG with sign of acute anterior MI with ST-elevation ≥ 2 mm in at least 2 of the following leads I, AVL, V1-V6, or ECG with sign of acute inferoposterior MI with ST-elevation ≥1 mm on all of the following leads- II, III, V5-V6 or STelevation ≥ 2 mm in at least 2 of the leads.\nThe target lesion located in the proximal section of the left anterior descending, left circumflex or right coronary artery.\nPatient with acute myocardial infarction within 10 days prior to IP administration.\nNormal liver and renal function.\nAble to understand study information provided to him.\nAble to give voluntary written consent.\n\nExclusion Criteria:\n\nHistory of acute/chronic inflammatory condition or severe aortic stenosis or insufficiency; severe mitral stenosis or severe mitral insufficiency.\nSevere co-morbidity associated with a reduction in life expectancy of less than 1 year.\nAdvanced renal dysfunction and creatinine ≥ 2mg%.\nAdvanced hepatic dysfunction.\nHave clinically serious and/or unstable intercurrent infection, medical illnesses or conditions that are uncontrolled or whose control, in the opinion of the Investigator, may be jeopardized by participation in this study or by the complications of this therapy",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "20 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Sreenivas Kumar, MD, DM",
            "OverallOfficialAffiliation": "Care Hospital, Hyderabad",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Satya Gupta",
            "OverallOfficialAffiliation": "SAL Hospital, Ahmedabad",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "R Keshava, MD, DM",
            "OverallOfficialAffiliation": "Bhagwan Mahaveer JAin Hospital, Bangalore",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Prakash VS, MD., DM",
            "OverallOfficialAffiliation": "MS Ramaiah Memorial Hospital, Bangalore",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Care Hospital",
            "LocationCity": "Hyderabad",
            "LocationState": "Andhra Pradesh",
            "LocationZip": "500034",
            "LocationCountry": "India"
          },
          {
            "LocationFacility": "SAL Hospital and Medical Institute",
            "LocationCity": "Ahmedabad",
            "LocationState": "Gujarat",
            "LocationZip": "380054",
            "LocationCountry": "India"
          },
          {
            "LocationFacility": "MS Ramaiah Memorial Hospital",
            "LocationCity": "Bangalore",
            "LocationState": "Karnataka",
            "LocationZip": "560054",
            "LocationCountry": "India"
          },
          {
            "LocationFacility": "Bhagawan Mahaveer Jain Heart Centre",
            "LocationCity": "Bangalore",
            "LocationState": "Karnataka",
            "LocationZip": "5660052",
            "LocationCountry": "India"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "25484310",
            "ReferenceType": "derived",
            "ReferenceCitation": "Chullikana A, Majumdar AS, Gottipamula S, Krishnamurthy S, Kumar AS, Prakash VS, Gupta PK. Randomized, double-blind, phase I/II study of intravenous allogeneic mesenchymal stromal cells in acute myocardial infarction. Cytotherapy. 2015 Mar;17(3):250-61. doi: 10.1016/j.jcyt.2014.10.009. Epub 2014 Dec 4."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000009203",
            "ConditionMeshTerm": "Myocardial Infarction"
          },
          {
            "ConditionMeshId": "D000007238",
            "ConditionMeshTerm": "Infarction"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000007511",
            "ConditionAncestorTerm": "Ischemia"
          },
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000009336",
            "ConditionAncestorTerm": "Necrosis"
          },
          {
            "ConditionAncestorId": "D000017202",
            "ConditionAncestorTerm": "Myocardial Ischemia"
          },
          {
            "ConditionAncestorId": "D000006331",
            "ConditionAncestorTerm": "Heart Diseases"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          },
          {
            "ConditionAncestorId": "D000014652",
            "ConditionAncestorTerm": "Vascular Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M11307",
            "ConditionBrowseLeafName": "Myocardial Infarction",
            "ConditionBrowseLeafAsFound": "Myocardial Infarction",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9434",
            "ConditionBrowseLeafName": "Infarction",
            "ConditionBrowseLeafAsFound": "Infarction",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M1072",
            "ConditionBrowseLeafName": "ST Elevation Myocardial Infarction",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11436",
            "ConditionBrowseLeafName": "Necrosis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5698",
            "ConditionBrowseLeafName": "Coronary Artery Disease",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M18658",
            "ConditionBrowseLeafName": "Myocardial Ischemia",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8571",
            "ConditionBrowseLeafName": "Heart Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16552",
            "ConditionBrowseLeafName": "Vascular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "C000012499",
            "InterventionMeshTerm": "Plasma-lyte 148"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000009883",
            "InterventionAncestorTerm": "Ophthalmic Solutions"
          },
          {
            "InterventionAncestorId": "D000019999",
            "InterventionAncestorTerm": "Pharmaceutical Solutions"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M85407",
            "InterventionBrowseLeafName": "Plasma-lyte 148",
            "InterventionBrowseLeafAsFound": "Fluorescein",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M21013",
            "InterventionBrowseLeafName": "Pharmaceutical Solutions",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M11966",
            "InterventionBrowseLeafName": "Ophthalmic Solutions",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "PhSol",
            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}